Xie Li-min, Wang Wen-yue
Department of Orthopedics, Guang' anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Zhong Xi Yi Jie He Xue Bao. 2012 Feb;10(2):160-5. doi: 10.3736/jcim20120206.
Clinical practice guidelines play an important role in practitioner and patient decisions regarding appropriate clinical health care and in health policy formation. In the guideline development process, inappropriate methodologies and development strategies significantly influence the quality of guidelines; therefore, research and evaluation of guidelines have great significance. The original Appraisal of Guidelines for Research and Evaluation (AGREE) instrument was published in 2003 by a group of international guideline developers and researchers. AGREE has important significance for the quality guarantee and successful implementation of guidelines, and has extensively achieved endorsement since 2003. In 2009, The AGREE Collaboration has developed the AGREE II by refining the original AGREE instrument. At present, the AGREE II has already replaced the original AGREE instrument; however, related introduction regarding AGREE II has not been found in China. The authors of this article briefly introduce the AGREE II, and believe that it will add value to research and evaluation of the guidelines.
临床实践指南在从业者和患者做出有关适当临床医疗保健的决策以及卫生政策制定方面发挥着重要作用。在指南制定过程中,不恰当的方法和制定策略会显著影响指南的质量;因此,对指南的研究和评估具有重大意义。最初的《研究与评价指南评估(AGREE)工具》由一群国际指南制定者和研究人员于2003年发布。AGREE对于指南的质量保证和成功实施具有重要意义,自2003年以来已广泛获得认可。2009年,AGREE协作组织通过完善原始的AGREE工具开发了AGREE II。目前,AGREE II已取代了原始的AGREE工具;然而,在中国尚未发现有关AGREE II的相关介绍。本文作者简要介绍了AGREE II,并认为它将为指南的研究和评估增添价值。